Details:

Alternative Title:
J Acquir Immune Defic Syndr
Publisher's site:
http://dx.doi.org/10.1097/QAI.0000000000000975
Personal Author:
Butler, Katherine ; Ritter, Jana M. ; Ellis, Shanon ; Morris, Monica R. ; Hanson, Debra L. ; ... More +
Butler, Katherine ; Ritter, Jana M. ; Ellis, Shanon ; Morris, Monica R. ; Hanson, Debra L. ; McNicholl, Janet M. ; Kersh, Ellen N. Less -
Description:
Introduction

Hormonal contraception with DMPA may increase HIV acquisition risk, but observational human studies are inconclusive, and animal models can help investigate this risk. Here we test the impact of a low DMPA dose, designed to resemble human contraceptive use, on SHIV acquisition risk in pigtail macaques (Macaca nemestrina).

Methods

Macaques metabolize DMPA faster than humans. We previously identified a per-weight DMPA dose and administration frequency that achieves long-lasting suppression of ovulation in macaques. Eight macaques were given 1.5 mg/kg DMPA monthly, while eleven were untreated controls. For comparison, women receive 150 mg (approximately 2 mg/kg) every 3 months. We exposed monkeys to 20 sub-optimal SHIV challenges, designed to slowly infect half of controls and allow increased infection in the DMPA group.

Results

It took a median 5.5 viral challenges to infect DMPA-treated macaques, and 9 challenges for controls (p=0.27; exact conditional logistic regression). The exact odds ratio was 2.2 (CI 0.6 – 8.3). Ovulation was suppressed, and the vaginal epithelium was thinned after DMPA-treatment in all animals (mean 30 and 219 micrometers in DMPA-treated and control macaques, respectively, p=0.03, t-test using the Satterthwaite degrees-of-freedom approximation).

Conclusions

SHIV infections in DMPA treated macaques were 2.2 times those of controls, but this was not statistically significant. The result is remarkably similar to studies of human DMPA use, which have shown HIV risk increases of a similar magnitude and of variable significance. Taken together with previous studies of higher DMPA doses in macaques, the results suggest a dose-dependent effect of DMPA on SIV or SHIV acquisition.


Subjects:
[+]
Acquisition Risk Article HIV Hormonal Contraception Macaque Model
Source:
J Acquir Immune Defic Syndr. 72(4):363-371.
Pubmed ID:
27355414
Pubmed Central ID:
PMC4930010
Document Type:
Journal Article
Funding:
CC999999/Intramural CDC HHS/United States ; Y01 AI000681-02/AI/NIAID NIH HHS/United States
CC999999/Intramural CDC HHS/United States ; Y01 AI000681-02/AI/NIAID NIH HHS/United States Less -
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:0ff9d68e057d515646a45d92f54d071f97bce291dcf1a7890f0fdc6e381ddcd9
Download URL:
https://stacks.cdc.gov/view/cdc/40318/cdc_40318_DS1.pdf
File Type:

Supporting Files

• 	nihms-761722-f0005.gif	gif
  	nihms-761722-f0005.jpg	jpeg
  	nihms-761722.nxml	bin
  	NIHMS761722-supplement-Supplemental_Digital_Content.docx	docx
  	nihms-761722-f0001.gif	gif
  	nihms-761722-f0001.jpg	jpeg
  	nihms-761722-f0002.gif	gif
  	nihms-761722-f0002.jpg	jpeg
  	nihms-761722-f0003.gif	gif
  	nihms-761722-f0003.jpg	jpeg
  	nihms-761722-f0004.gif	gif
  	nihms-761722-f0004.jpg	jpeg

More +